<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Flu Vaccine News Heating Up</title><link>http://articles.mercola.com/sites/articles/archive/2005/08/04/flu-vaccine-part-fourteen.aspx</link><description>In the 2004 flu season, Chiron cut its production of flu vaccine doses for the U.S. market by almost half--due to quality control issues at its plant in Liverpool, England. With the 2005 flu season rapidly approaching, it appears the company will again</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>